# A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers

> **NCT00913250** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 96 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Serum containing Avonex
- **DRUG:** Serum Free Avonex

## Key facts

- **NCT ID:** NCT00913250
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2003-10
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2009-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00913250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00913250, "A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00913250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*